Oxygen-free radical decrease in hypertensive patients treated with lercanidipine

International Angiology

Volumn 20, Issue 2, 2001, Pages 136-140

  Incandela, L ^a   Belcaro, G ^a   Cesarone, M R ^a   De Sanctis, M T ^a   Griffin, M ^a   Cacchio, M ^a   Nicolaides, A N ^a   Bucci, M ^a   Barsotti, A ^a   Martines, G ^a   Cornelli, U ^a   Di Renzo, A ^a  

^a NONE   (Italy)

Author keywords

Atherosclerosis; Free radicals; Hypertension; Lercanidipine; Mass, screening; Monitoring, physiologic methods; Oxidative stress

Indexed keywords

LERCANIDIPINE; LIPOPROTEIN; OXYGEN RADICAL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; DRUG TOLERABILITY; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; HYPERTENSION; IN VIVO STUDY; MALE; MEASUREMENT; MICROCIRCULATION; OXIDATIVE STRESS; PATIENT MONITORING; PROTECTION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIHYDROPYRIDINES; ELECTROCARDIOGRAPHY; FEMALE; FREE RADICALS; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; TIME FACTORS;

EID: 0034757326     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The evolution of oxidative stress indicators in the course of myocardial ischemia
2. The free radical system in ischemic heart disease
3. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes
4. Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress?
5. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus
6. Three models of free radical-induced cell injury
7. Endothelial dysfunction in myocardial ischemia and reperfusion: Role of oxygen-derived free radicals
8. Reactive metabolites of oxygen, lipid peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension
9. Spin trapping and associated vocabulary
10. Oxygen radicals in biological systems
11. Assessing oxidative stress with the D-Roms test. Some mechanistic considerations
12. A simple test to monitor oxidative stress
13. The organ damage in arterial hypertension
14. Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertension
15. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension
16. Hypertensive retinal vascular changes: Relationship to left ventricular hypertrophy and arteriolar changes before and after treatment
17. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension
18. Albuminuria in untreated patients with primary aldosteronism or essential hypertension
19. Renal damage in hypertension
20. Relationship between blood pressure and renal function
21. Myocardial hypertrophy and arterial hypertension
22. Evaluation of cardiac damage in hypertension
23. Diabetic and hypertensive heart disease
24. Vasa vasorum visualised by power-Doppler in normal and arteriosclerotic carotid arteries
25. Noninvasive investigations in vascular disease
26. Laser Doppler flux in normal and arteriosclerotic carotid artery wall
27. Microcirculation in systemic hypertension
28. Retinal duplex scanning in cerebrovascular disease and hypertension
29. Pressure and microcirculatory effects of treatment with Lercanidipine in hypertensive patients and in vascular patients with hypertension
30. Microcirculation and arterial hypertension
31. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinical and ambulatory blood pressure measurements. Multicenter Study Investigators
32. Clinical advantages of lipophilic dihydropyridines
33. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension
34. Free radicals, antioxidants and human disease: Curiosity, cause or consequence
35. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists